Strahlentherapie und Onkologie, ISSN 0179-7158, 10/2009, Volume 185, Issue 10, pp. 682 - 688
Journal Article
STRAHLENTHERAPIE UND ONKOLOGIE, ISSN 0179-7158, 10/2009, Volume 185, Issue 10, pp. 682 - 688
Background and Purpose: In patients with head-and-neck cancer treated with chemoradiotherapy (CRT), a cisplatin-based regimen is often used. Several treatment...
RANDOMIZED-TRIAL | CERVICAL-CANCER | TOXICITY | Chemoradiotherapy | Cisplatin | RADIATION-THERAPY | Head-and-neck cancer | CONCOMITANT CHEMOTHERAPY | RADIOCHEMOTHERAPY | ONCOLOGY | Cumulative dose | SQUAMOUS-CELL CARCINOMA | LOCALLY ADVANCED HEAD | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CONCURRENT CHEMORADIOTHERAPY | Otorhinolaryngologic Neoplasms - drug therapy | Lymphatic Metastasis - radiotherapy | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Otorhinolaryngologic Neoplasms - pathology | Otorhinolaryngologic Neoplasms - radiotherapy | Male | Antineoplastic Agents - administration & dosage | Carcinoma, Squamous Cell - radiotherapy | Cisplatin - administration & dosage | Dose-Response Relationship, Drug | Carcinoma, Squamous Cell - mortality | Radiation-Sensitizing Agents - administration & dosage | Antineoplastic Agents - adverse effects | Lymphatic Metastasis - pathology | Adult | Dose Fractionation | Female | Otorhinolaryngologic Neoplasms - mortality | Radiotherapy Planning, Computer-Assisted | Drug Administration Schedule | Kaplan-Meier Estimate | Radiotherapy, High-Energy | Actuarial Analysis | Combined Modality Therapy | Radiation-Sensitizing Agents - adverse effects | Carcinoma, Squamous Cell - drug therapy | Cisplatin - adverse effects | Aged | Neoplasm Staging | Index Medicus
RANDOMIZED-TRIAL | CERVICAL-CANCER | TOXICITY | Chemoradiotherapy | Cisplatin | RADIATION-THERAPY | Head-and-neck cancer | CONCOMITANT CHEMOTHERAPY | RADIOCHEMOTHERAPY | ONCOLOGY | Cumulative dose | SQUAMOUS-CELL CARCINOMA | LOCALLY ADVANCED HEAD | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CONCURRENT CHEMORADIOTHERAPY | Otorhinolaryngologic Neoplasms - drug therapy | Lymphatic Metastasis - radiotherapy | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Otorhinolaryngologic Neoplasms - pathology | Otorhinolaryngologic Neoplasms - radiotherapy | Male | Antineoplastic Agents - administration & dosage | Carcinoma, Squamous Cell - radiotherapy | Cisplatin - administration & dosage | Dose-Response Relationship, Drug | Carcinoma, Squamous Cell - mortality | Radiation-Sensitizing Agents - administration & dosage | Antineoplastic Agents - adverse effects | Lymphatic Metastasis - pathology | Adult | Dose Fractionation | Female | Otorhinolaryngologic Neoplasms - mortality | Radiotherapy Planning, Computer-Assisted | Drug Administration Schedule | Kaplan-Meier Estimate | Radiotherapy, High-Energy | Actuarial Analysis | Combined Modality Therapy | Radiation-Sensitizing Agents - adverse effects | Carcinoma, Squamous Cell - drug therapy | Cisplatin - adverse effects | Aged | Neoplasm Staging | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2010, Volume 28, Issue 27, pp. 4199 - 4206
Purpose Combined-modality treatment consisting of four to six cycles of chemotherapy followed by involved-field radiotherapy (IFRT) is the standard of care for...
POSITRON-EMISSION-TOMOGRAPHY | THERAPY | ONCOLOGY | NODE RADIOTHERAPY | DISEASE | CYCLES | SUPERIOR | STAGE-I | INTERNATIONAL PROGNOSTIC SCORE | RADIATION | PROGRESSION | Procarbazine - administration & dosage | Cyclophosphamide - administration & dosage | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - administration & dosage | Young Adult | Hodgkin Disease - radiotherapy | Time Factors | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Vincristine - administration & dosage | Adult | Female | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Doxorubicin - administration & dosage | Dacarbazine - administration & dosage | Prednisone - administration & dosage | Europe | Kaplan-Meier Estimate | Etoposide - administration & dosage | Treatment Outcome | Bleomycin - administration & dosage | Bleomycin - adverse effects | Radiation Dosage | Disease-Free Survival | Adolescent | Aged | Doxorubicin - adverse effects | Index Medicus
POSITRON-EMISSION-TOMOGRAPHY | THERAPY | ONCOLOGY | NODE RADIOTHERAPY | DISEASE | CYCLES | SUPERIOR | STAGE-I | INTERNATIONAL PROGNOSTIC SCORE | RADIATION | PROGRESSION | Procarbazine - administration & dosage | Cyclophosphamide - administration & dosage | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - administration & dosage | Young Adult | Hodgkin Disease - radiotherapy | Time Factors | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Vincristine - administration & dosage | Adult | Female | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Doxorubicin - administration & dosage | Dacarbazine - administration & dosage | Prednisone - administration & dosage | Europe | Kaplan-Meier Estimate | Etoposide - administration & dosage | Treatment Outcome | Bleomycin - administration & dosage | Bleomycin - adverse effects | Radiation Dosage | Disease-Free Survival | Adolescent | Aged | Doxorubicin - adverse effects | Index Medicus
Journal Article
Strahlentherapie und Onkologie, ISSN 0179-7158, 2001, Volume 177, Issue 4, pp. 173 - 181
Journal Article
Journal of Neurosurgery, ISSN 0022-3085, 2001, Volume 95, Issue 2, pp. 225 - 231
Journal Article
PLoS genetics, ISSN 1553-7390, 2008, Volume 4, Issue 4, p. e1000054
A three-stage genome-wide association study recently identified single nucleotide polymorphisms (SNPs) in five loci (fibroblast growth receptor 2 (FGFR2),...
APOPTOSIS | KERATINOCYTE GROWTH-FACTOR | COLORECTAL-CANCER | PROSTATE-CANCER | GENETICS & HEREDITY | RECEPTOR | RISK | PATTERNS | EXPRESSION | FGFR2 | GENOME-WIDE ASSOCIATION | Trinucleotide Repeats | Chromosomes, Human, Pair 8 - genetics | Genetic Predisposition to Disease | Humans | Middle Aged | Receptors, Progesterone - genetics | Case-Control Studies | Linkage Disequilibrium | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Female | MAP Kinase Kinase Kinase 1 - genetics | Polymorphism, Single Nucleotide | Odds Ratio | Microfilament Proteins - genetics | Receptor, Fibroblast Growth Factor, Type 2 - genetics | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN | Disease prevention | Medical research | Hypotheses | Hospitals | Disease | Breast cancer | Genomes | Kinases | Epidemiology
APOPTOSIS | KERATINOCYTE GROWTH-FACTOR | COLORECTAL-CANCER | PROSTATE-CANCER | GENETICS & HEREDITY | RECEPTOR | RISK | PATTERNS | EXPRESSION | FGFR2 | GENOME-WIDE ASSOCIATION | Trinucleotide Repeats | Chromosomes, Human, Pair 8 - genetics | Genetic Predisposition to Disease | Humans | Middle Aged | Receptors, Progesterone - genetics | Case-Control Studies | Linkage Disequilibrium | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Female | MAP Kinase Kinase Kinase 1 - genetics | Polymorphism, Single Nucleotide | Odds Ratio | Microfilament Proteins - genetics | Receptor, Fibroblast Growth Factor, Type 2 - genetics | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN | Disease prevention | Medical research | Hypotheses | Hospitals | Disease | Breast cancer | Genomes | Kinases | Epidemiology
Journal Article
Strahlentherapie und Onkologie, ISSN 0179-7158, 10/2009, Volume 185, Issue 10, pp. 682 - 688
In patients with head-and-neck cancer treated with chemoradiotherapy (CRT), a cisplatin-based regimen is often used. Several treatment schedules are accepted...
Journal Article
Strahlentherapie und Onkologie, ISSN 0179-7158, 10/2009, Volume 185, Issue 10, p. 682
In patients with head-and-neck cancer treated with chemoradiotherapy (CRT), a cisplatin-based regimen is often used. Several treatment schedules are accepted...
Cancer patients | Care and treatment | Analysis | Radiation | Radiotherapy | Cisplatin | Cancer
Cancer patients | Care and treatment | Analysis | Radiation | Radiotherapy | Cisplatin | Cancer
Journal Article
Deutsches Arzteblatt, ISSN 0012-1207, 09/2009, Volume 106, Issue 37, pp. A1776 - A1780
Journal Article
Human Molecular Genetics, ISSN 0964-6906, 12/2011, Volume 20, Issue 23, pp. 4693 - 4706
A genome-wide association study (GWAS) identified single-nucleotide polymorphisms (SNPs) at 1p11.2 and 14q24.1 (RAD51L1) as breast cancer susceptibility loci....
ALLELES | METAANALYSIS | GLUCOSE | BIOCHEMISTRY & MOLECULAR BIOLOGY | GENETICS & HEREDITY | CONFER SUSCEPTIBILITY | BRCA1 | LOCUS | GENOME-WIDE ASSOCIATION | Breast Neoplasms - classification | Confidence Intervals | Genetic Predisposition to Disease | Genome-Wide Association Study | Receptors, Estrogen - metabolism | Humans | Risk Factors | Receptor, ErbB-2 - metabolism | DNA-Binding Proteins - genetics | Case-Control Studies | Genetic Heterogeneity | Receptors, Progesterone - metabolism | Breast Neoplasms - genetics | Alleles | Polymorphism, Single Nucleotide - genetics | Female | Chromosomes, Human, Pair 1 - genetics | Odds Ratio | Chromosomes, Human, Pair 14 - genetics | Association Studies
ALLELES | METAANALYSIS | GLUCOSE | BIOCHEMISTRY & MOLECULAR BIOLOGY | GENETICS & HEREDITY | CONFER SUSCEPTIBILITY | BRCA1 | LOCUS | GENOME-WIDE ASSOCIATION | Breast Neoplasms - classification | Confidence Intervals | Genetic Predisposition to Disease | Genome-Wide Association Study | Receptors, Estrogen - metabolism | Humans | Risk Factors | Receptor, ErbB-2 - metabolism | DNA-Binding Proteins - genetics | Case-Control Studies | Genetic Heterogeneity | Receptors, Progesterone - metabolism | Breast Neoplasms - genetics | Alleles | Polymorphism, Single Nucleotide - genetics | Female | Chromosomes, Human, Pair 1 - genetics | Odds Ratio | Chromosomes, Human, Pair 14 - genetics | Association Studies
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2002, Volume 54, Issue 4, pp. 1160 - 1164
Purpose: The optimum fractionation schedule for radiotherapy (RT) of metastatic spinal cord compression (MSCC) is still debated in the literature. Several...
Radiation schedule | Metastatic spinal cord compression | Palliation | SURVIVAL | MANAGEMENT | SINGLE | BONE METASTASES | radiation schedule | TUMOR | PROSPECTIVE TRIAL | RADIATION-THERAPY | RANDOMIZED TRIAL | metastatic spinal cord compression | palliation | ONCOLOGY | PAIN RELIEF | DEFICITS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Humans | Middle Aged | Spinal Cord Neoplasms - secondary | Male | Motor Activity | Spinal Cord Compression - complications | Dose Fractionation, Radiation | Radiotherapy - methods | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Spinal Cord Neoplasms - radiotherapy
Radiation schedule | Metastatic spinal cord compression | Palliation | SURVIVAL | MANAGEMENT | SINGLE | BONE METASTASES | radiation schedule | TUMOR | PROSPECTIVE TRIAL | RADIATION-THERAPY | RANDOMIZED TRIAL | metastatic spinal cord compression | palliation | ONCOLOGY | PAIN RELIEF | DEFICITS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Humans | Middle Aged | Spinal Cord Neoplasms - secondary | Male | Motor Activity | Spinal Cord Compression - complications | Dose Fractionation, Radiation | Radiotherapy - methods | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Spinal Cord Neoplasms - radiotherapy
Journal Article
Radiotherapy and Oncology, ISSN 0167-8140, 2007, Volume 83, Issue 3, pp. 283 - 288
Abstract Background Prostate cancer is associated with defective DNA strand break repair after DNA damage leading to genetic instability and prostate cancer...
Hematology, Oncology and Palliative Medicine | Late effects | Brachytherapy | ATM germline mutation | Prostate cancer | GENE-MUTATIONS | DNA-DAMAGE | HETEROZYGOTES | A-T | SEQUENCE VARIANTS | INTERSTITIAL BRACHYTHERAPY | prostate cancer | REPAIR | POLYMORPHISMS | ONCOLOGY | brachytherapy | RADIOSENSITIVITY | ATAXIA-TELANGIECTASIA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | late effects | Genetic Predisposition to Disease | Follow-Up Studies | Humans | Middle Aged | Protein-Serine-Threonine Kinases - genetics | Male | Ataxia Telangiectasia Mutated Proteins | Mutation, Missense | DNA-Binding Proteins - genetics | Prostatic Neoplasms - genetics | Tumor Suppressor Proteins - genetics | Age of Onset | Cell Cycle Proteins - genetics | Heterozygote | Amino Acid Substitution | Development and progression
Hematology, Oncology and Palliative Medicine | Late effects | Brachytherapy | ATM germline mutation | Prostate cancer | GENE-MUTATIONS | DNA-DAMAGE | HETEROZYGOTES | A-T | SEQUENCE VARIANTS | INTERSTITIAL BRACHYTHERAPY | prostate cancer | REPAIR | POLYMORPHISMS | ONCOLOGY | brachytherapy | RADIOSENSITIVITY | ATAXIA-TELANGIECTASIA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | late effects | Genetic Predisposition to Disease | Follow-Up Studies | Humans | Middle Aged | Protein-Serine-Threonine Kinases - genetics | Male | Ataxia Telangiectasia Mutated Proteins | Mutation, Missense | DNA-Binding Proteins - genetics | Prostatic Neoplasms - genetics | Tumor Suppressor Proteins - genetics | Age of Onset | Cell Cycle Proteins - genetics | Heterozygote | Amino Acid Substitution | Development and progression
Journal Article
Zeitschrift fuer Medizinische Physik, ISSN 0939-3889, 2006, Volume 16, Issue 2, pp. 155 - 159
Bei der Inbetriebnahme eines TL-Readers vom Typ Harshaw 5500 wurden Ungenauigkeiten bei der Aufnahme von Glühkurven festgestellt. Diese zeigen sich in der...
TL-Reader | Glühkurve | Thermolumineszenzdosimetrie | Thermoluminescent dosimetry | glowcurve | Glowcurve
TL-Reader | Glühkurve | Thermolumineszenzdosimetrie | Thermoluminescent dosimetry | glowcurve | Glowcurve
Journal Article
International Journal of Colorectal Disease, ISSN 0179-1958, 2009, Volume 24, Issue 12, pp. 1421 - 1428
The purpose of this study was the evaluation of the feasibility and outcome of definitive radio-chemotherapy without split-course technique but with...
Radio-chemotherapy | Toxicity | Anal cancer | Outcome | SURGERY | CANAL CARCINOMA | CONSERVATIVE TREATMENT | PROGNOSTIC-FACTORS | EUROPEAN ORGANIZATION | RANDOMIZED-TRIAL | TREATMENT TIME | RADIATION-THERAPY | GASTROINTESTINAL COOPERATIVE GROUPS | LOCAL-CONTROL | RETROSPECTIVE ANALYSIS | GASTROENTEROLOGY & HEPATOLOGY | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Radiotherapy - adverse effects | Time Factors | Antineoplastic Agents - adverse effects | Anus Neoplasms - drug therapy | Anus Neoplasms - radiotherapy | Aged, 80 and over | Adult | Female | Aged | Care and treatment | Research | Oncology, Experimental | Cancer | Index Medicus
Radio-chemotherapy | Toxicity | Anal cancer | Outcome | SURGERY | CANAL CARCINOMA | CONSERVATIVE TREATMENT | PROGNOSTIC-FACTORS | EUROPEAN ORGANIZATION | RANDOMIZED-TRIAL | TREATMENT TIME | RADIATION-THERAPY | GASTROINTESTINAL COOPERATIVE GROUPS | LOCAL-CONTROL | RETROSPECTIVE ANALYSIS | GASTROENTEROLOGY & HEPATOLOGY | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Radiotherapy - adverse effects | Time Factors | Antineoplastic Agents - adverse effects | Anus Neoplasms - drug therapy | Anus Neoplasms - radiotherapy | Aged, 80 and over | Adult | Female | Aged | Care and treatment | Research | Oncology, Experimental | Cancer | Index Medicus
Journal Article
ZEITSCHRIFT FUR MEDIZINISCHE PHYSIK, ISSN 0939-3889, 2006, Volume 16, Issue 2, pp. 155 - 159
Putting into operation a TL Reader Type Harshaw 5500 revealed some inaccuracies in the acquisition of glowcurves, i.e., a shift of the glowcurves upon exposure...
TL-Reader | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Thermoluminescent dosimetry | glowcurve | THERMOLUMINESCENCE | Radiotherapy Dosage | Thermodynamics | Reproducibility of Results | Temperature | Humans | Thermoluminescent Dosimetry - instrumentation | Thermoluminescent Dosimetry - methods | Hearing - physiology | Equipment Design
TL-Reader | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Thermoluminescent dosimetry | glowcurve | THERMOLUMINESCENCE | Radiotherapy Dosage | Thermodynamics | Reproducibility of Results | Temperature | Humans | Thermoluminescent Dosimetry - instrumentation | Thermoluminescent Dosimetry - methods | Hearing - physiology | Equipment Design
Journal Article
Strahlentherapie und Onkologie, ISSN 0179-7158, 3/2001, Volume 177, Issue 4, pp. 173 - 181
The standard treatment for patients with clinically resectable rectal cancer is surgery. Postoperative radiochemotherapy is recommended for patients with...
Neoadjuvant/adjuvant radiochemotherapy | Phase-III trial | Schlüsselwörter: Rektumkarzinom | Neoadjuvante/adjuvante Radiochemotherapie | Key Words: Rectal cancer | Phase-III-Studie | SURGERY | rectal cancer | POSTOPERATIVE RADIOTHERAPY | FOLLOW-UP | TOTAL MESORECTAL EXCISION | phase-III trial | PREOPERATIVE RADIATION | radiochemotherapy | CONCURRENT 5-FLUOROURACIL | THERAPY | ONCOLOGY | DOSE LEUCOVORIN | neoadjuvant/adjuvant | QUALITY-OF-LIFE | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Radiotherapy Dosage | Postoperative Complications - etiology | Rectal Neoplasms - surgery | Humans | Middle Aged | Male | Treatment Outcome | Rectal Neoplasms - radiotherapy | Antimetabolites, Antineoplastic - administration & dosage | Patient Selection | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Chemotherapy, Adjuvant - adverse effects | Neoadjuvant Therapy - adverse effects | Radiotherapy, Adjuvant - adverse effects | Antimetabolites, Antineoplastic - adverse effects | Survival Analysis | Quality of Life | Adult | Female | Aged | Rectal Neoplasms - pathology | Neoplasm Staging | Rectal Neoplasms - drug therapy | Surgical outcomes | Wound healing | Cancer therapies | Surgery | Cancer
Neoadjuvant/adjuvant radiochemotherapy | Phase-III trial | Schlüsselwörter: Rektumkarzinom | Neoadjuvante/adjuvante Radiochemotherapie | Key Words: Rectal cancer | Phase-III-Studie | SURGERY | rectal cancer | POSTOPERATIVE RADIOTHERAPY | FOLLOW-UP | TOTAL MESORECTAL EXCISION | phase-III trial | PREOPERATIVE RADIATION | radiochemotherapy | CONCURRENT 5-FLUOROURACIL | THERAPY | ONCOLOGY | DOSE LEUCOVORIN | neoadjuvant/adjuvant | QUALITY-OF-LIFE | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Radiotherapy Dosage | Postoperative Complications - etiology | Rectal Neoplasms - surgery | Humans | Middle Aged | Male | Treatment Outcome | Rectal Neoplasms - radiotherapy | Antimetabolites, Antineoplastic - administration & dosage | Patient Selection | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Chemotherapy, Adjuvant - adverse effects | Neoadjuvant Therapy - adverse effects | Radiotherapy, Adjuvant - adverse effects | Antimetabolites, Antineoplastic - adverse effects | Survival Analysis | Quality of Life | Adult | Female | Aged | Rectal Neoplasms - pathology | Neoplasm Staging | Rectal Neoplasms - drug therapy | Surgical outcomes | Wound healing | Cancer therapies | Surgery | Cancer
Journal Article
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], ISSN 0179-7158, 06/2002, Volume 178, Issue 6, p. 336
Meningeal melanocytoma is described as rare benign lesion with a high risk of recurrence. There are no well-substantiated treatment recommendations in the...
Neoplasm Recurrence, Local - radiotherapy | Nevus - mortality | Melanoma - diagnosis | Prognosis | Follow-Up Studies | Neoplasm, Residual - surgery | Humans | Middle Aged | Male | Meningeal Neoplasms - diagnosis | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - surgery | Neoplasm, Residual - diagnosis | Adult | Female | Neoplasm, Residual - radiotherapy | Neoplasm, Residual - mortality | Radiotherapy, Adjuvant | Nevus - diagnosis | Melanoma - radiotherapy | Survival Rate | Neoplasm Recurrence, Local - diagnosis | Cranial Irradiation | Nevus - surgery | Meningeal Neoplasms - mortality | Magnetic Resonance Imaging | Nevus - radiotherapy | Meningeal Neoplasms - surgery | Adolescent | Aged | Meningeal Neoplasms - radiotherapy | Melanoma - surgery | Melanoma - mortality
Neoplasm Recurrence, Local - radiotherapy | Nevus - mortality | Melanoma - diagnosis | Prognosis | Follow-Up Studies | Neoplasm, Residual - surgery | Humans | Middle Aged | Male | Meningeal Neoplasms - diagnosis | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - surgery | Neoplasm, Residual - diagnosis | Adult | Female | Neoplasm, Residual - radiotherapy | Neoplasm, Residual - mortality | Radiotherapy, Adjuvant | Nevus - diagnosis | Melanoma - radiotherapy | Survival Rate | Neoplasm Recurrence, Local - diagnosis | Cranial Irradiation | Nevus - surgery | Meningeal Neoplasms - mortality | Magnetic Resonance Imaging | Nevus - radiotherapy | Meningeal Neoplasms - surgery | Adolescent | Aged | Meningeal Neoplasms - radiotherapy | Melanoma - surgery | Melanoma - mortality
Journal Article
Strahlentherapie und Onkologie, ISSN 0179-7158, 08/1999, Volume 175, Issue 8, pp. 382 - 386
Background: Although effectiveness of fractionated radiotherapy for painful bone metastases is well documented, there are unanswered questions regarding the...
Fractionation | Pain relief | Radiotherapy | Bone metastases | fractionation | SINGLE | RELIEF | PALLIATION | RADIATION-THERAPY | IRRADIATION | MANAGEMENT POLICY | ONCOLOGY | radiotherapy | bone metastases | PROSPECTIVE RANDOMIZED TRIAL | pain relief | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCHEDULES | Pain, Intractable - etiology | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Bone Neoplasms - secondary | Male | Treatment Outcome | Pain, Intractable - radiotherapy | Bone Neoplasms - complications | Bone Neoplasms - radiotherapy | Time Factors | Survival Analysis | Dose Fractionation | Female | Aged | Dose-Response Relationship, Radiation
Fractionation | Pain relief | Radiotherapy | Bone metastases | fractionation | SINGLE | RELIEF | PALLIATION | RADIATION-THERAPY | IRRADIATION | MANAGEMENT POLICY | ONCOLOGY | radiotherapy | bone metastases | PROSPECTIVE RANDOMIZED TRIAL | pain relief | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCHEDULES | Pain, Intractable - etiology | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Bone Neoplasms - secondary | Male | Treatment Outcome | Pain, Intractable - radiotherapy | Bone Neoplasms - complications | Bone Neoplasms - radiotherapy | Time Factors | Survival Analysis | Dose Fractionation | Female | Aged | Dose-Response Relationship, Radiation
Journal Article
Strahlentherapie und Onkologie, ISSN 0179-7158, 08/1999, Volume 175, Issue 8, p. 378
In einer retrospektiven Analyse wurde die prognostische Bedeutung des Zeitraums vom Auftreten erster motorischer Defizite bis zum Bestrahlungsbeginn fur die...
Analysis | Metastasis | Health aspects
Analysis | Metastasis | Health aspects
Journal Article
Strahlentherapie und Onkologie, ISSN 0179-7158, 10/2002, Volume 178, Issue 10, pp. 556 - 561
Patients with metastatic spinal cord compression are often presented for emergency radiotherapy. The optimum radiotherapeutic regimen is still debated, studies...
Behandlungsschema | Radiation schedule | Key Words: Metastatic spinal cord compression | Palliative irradiation | Schlüsselwörter: Metastatisch bedingte Rückenmarkskompression | Palliative Strahlentherapie | Metastatic spinal cord compression | SURVIVAL | MANAGEMENT | BONE METASTASES | radiation schedule | PROSPECTIVE TRIAL | RANDOMIZED TRIAL | STRATEGIES | THERAPY | metastatic spinal cord compression | ONCOLOGY | palliative irradiation | DEVELOPING MOTOR DEFICITS | PAIN RELIEF | RADIOTHERAPY SCHEDULES | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prognosis | Humans | Middle Aged | Male | Neurologic Examination - radiation effects | Palliative Care | Spinal Cord Compression - radiotherapy | Activities of Daily Living - classification | Outcome and Process Assessment (Health Care) | Spinal Neoplasms - secondary | Aged, 80 and over | Adult | Dose Fractionation | Female | Aged | Retrospective Studies | Radiotherapy Planning, Computer-Assisted | Spinal Neoplasms - radiotherapy | Analysis | Metastasis | Multivariate analysis | Surgery | Radiation therapy
Behandlungsschema | Radiation schedule | Key Words: Metastatic spinal cord compression | Palliative irradiation | Schlüsselwörter: Metastatisch bedingte Rückenmarkskompression | Palliative Strahlentherapie | Metastatic spinal cord compression | SURVIVAL | MANAGEMENT | BONE METASTASES | radiation schedule | PROSPECTIVE TRIAL | RANDOMIZED TRIAL | STRATEGIES | THERAPY | metastatic spinal cord compression | ONCOLOGY | palliative irradiation | DEVELOPING MOTOR DEFICITS | PAIN RELIEF | RADIOTHERAPY SCHEDULES | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prognosis | Humans | Middle Aged | Male | Neurologic Examination - radiation effects | Palliative Care | Spinal Cord Compression - radiotherapy | Activities of Daily Living - classification | Outcome and Process Assessment (Health Care) | Spinal Neoplasms - secondary | Aged, 80 and over | Adult | Dose Fractionation | Female | Aged | Retrospective Studies | Radiotherapy Planning, Computer-Assisted | Spinal Neoplasms - radiotherapy | Analysis | Metastasis | Multivariate analysis | Surgery | Radiation therapy
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.